Eliglustat hemitartrate

Overview

Eliglustat hemitartrate is an specific, potent and orally active glucocerebroside synthase inhibitor with an IC 50 of 24 nM.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Glucosylceramide Synthase (GCS)

Product Information

• Catalog No.: HY-14885A
• CAS No.: 928659-70-5
• Molecular Formula: C50H78N4O14
• Molecular Weight: 959.17
• Purity: 98.93%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.75 mg/mL (2.87 mM); Clear solution
• Availability: In-stock

Source

Original product source